Fig. 3: Overall survival probability in the randomized versus the observation group patients. | Leukemia

Fig. 3: Overall survival probability in the randomized versus the observation group patients.

From: A multicenter prospective, randomized, placebo-controlled phase II/III trial for preemptive acute graft-versus-host disease therapy

Fig. 3

One year OS probability after HSCT is shown for all randomized (N = 91, black solid line), aGvHD_MS17 pattern positive patients (N = 91; CF > 0.1) and is compared to those of the observation group patients (N = 102, gray solid line) with only negative samples for the AGvHD_MS17 CF (CF < 0.1).

Back to article page